• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合以血浆循环蛋白为中心的多组学技术,以识别帕金森病认知障碍的潜在治疗靶点。

Integrating plasma circulating protein-centered multi-omics to identify potential therapeutic targets for Parkinsonian cognitive disorders.

作者信息

Tuersong Tayier, Yong Yu Xuan, Chen Yan, Li Pei Shan, Shataer Samire, Shataer Munire, Ma Liang Ying, Yang Xin Ling

机构信息

Department of Pharmacy, Xinjiang Key Laboratory of Neurological Diseases, Xinjiang Clinical Research Center for Nervous System Diseases, Second Affiliated Hospital of Xinjiang Medical University, Ürümqi, 830001, Xinjiang, People's Republic of China.

Department of Neurology, Xinjiang Clinical Research Center for Nervous System Diseases, Xinjiang Key Laboratory of Neurological Diseases, Second Affiliated Hospital of Xinjiang Medical University, Ürümqi, 830001, Xinjiang, People's Republic of China.

出版信息

J Transl Med. 2025 May 12;23(1):535. doi: 10.1186/s12967-025-06541-z.

DOI:10.1186/s12967-025-06541-z
PMID:40355913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12070786/
Abstract

BACKGROUND

Parkinson's disease (PD), the second most common neurodegenerative disease with notable clinical heterogeneity, has Parkinson disease dementia (PDD) that severely impacts patients' quality of life. As no effective treatment exists, this study aimed to find potential drug targets for PD cognitive disorders.

METHODS

Two-sample Mendelian randomization (MR) and transcriptome analysis were used to identify PD biomarkers. Protein-protein interaction (PPI), gene ontology (GO), and KEGG pathway analyses explored biological effects. A nomogram model was developed.

RESULTS

76 Mendelian randomization genes (MRGs) from MR and 1771 differentially expressed genes (DEGs) from the transcriptome were obtained. Three significant shared DEGs (S-DEGs) were identified, with USP8 and STXBP6 having strong diagnostic value for PDD. The nomogram model with these two genes showed enhanced predictive ability. These genes had physical interactions, co-localization, and correlated with ODC and NEU immune cells. USP8 was linked to five diseases, and STXBP6 to one.

CONCLUSION

USP8, STXBP6, and immune cells (ODC and NEU) associated with PDD were identified, offering new insights into PD progression.

摘要

背景

帕金森病(PD)是第二常见的神经退行性疾病,具有显著的临床异质性,其帕金森病痴呆(PDD)严重影响患者的生活质量。由于尚无有效治疗方法,本研究旨在寻找PD认知障碍的潜在药物靶点。

方法

采用两样本孟德尔随机化(MR)和转录组分析来识别PD生物标志物。蛋白质-蛋白质相互作用(PPI)、基因本体(GO)和KEGG通路分析探索生物学效应。构建了列线图模型。

结果

从MR中获得76个孟德尔随机化基因(MRG),从转录组中获得1771个差异表达基因(DEG)。鉴定出三个显著的共享DEG(S-DEG),其中USP8和STXBP6对PDD具有较强的诊断价值。包含这两个基因的列线图模型显示出增强的预测能力。这些基因存在物理相互作用、共定位,并与ODC和NEU免疫细胞相关。USP8与五种疾病相关,STXBP6与一种疾病相关。

结论

鉴定出与PDD相关的USP8、STXBP6和免疫细胞(ODC和NEU),为PD的进展提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/ca634aa8b3ae/12967_2025_6541_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/d4fc384c7118/12967_2025_6541_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/036a8bde7144/12967_2025_6541_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/767b00db97e9/12967_2025_6541_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/9de63d6180bd/12967_2025_6541_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/708f2137ab57/12967_2025_6541_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/8278b18c8cc9/12967_2025_6541_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/eadcb7338d55/12967_2025_6541_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/ca634aa8b3ae/12967_2025_6541_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/d4fc384c7118/12967_2025_6541_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/036a8bde7144/12967_2025_6541_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/767b00db97e9/12967_2025_6541_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/9de63d6180bd/12967_2025_6541_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/708f2137ab57/12967_2025_6541_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/8278b18c8cc9/12967_2025_6541_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/eadcb7338d55/12967_2025_6541_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02cb/12070786/ca634aa8b3ae/12967_2025_6541_Fig8_HTML.jpg

相似文献

1
Integrating plasma circulating protein-centered multi-omics to identify potential therapeutic targets for Parkinsonian cognitive disorders.整合以血浆循环蛋白为中心的多组学技术,以识别帕金森病认知障碍的潜在治疗靶点。
J Transl Med. 2025 May 12;23(1):535. doi: 10.1186/s12967-025-06541-z.
2
Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction.与多发性硬化症相关的多组学生物标志物:从孟德尔随机化到药物预测
Sci Rep. 2025 Mar 19;15(1):9421. doi: 10.1038/s41598-025-94303-8.
3
Combining Single-Cell RNA Sequencing and Mendelian Randomization to Explore Novel Drug Targets for Parkinson's Disease.结合单细胞RNA测序和孟德尔随机化来探索帕金森病的新型药物靶点
Mol Neurobiol. 2025 Jun;62(6):7380-7392. doi: 10.1007/s12035-025-04700-3. Epub 2025 Jan 31.
4
Multi-omics analysis reveals the genetic aging landscape of Parkinson's disease.多组学分析揭示帕金森病的遗传衰老图景。
Sci Rep. 2024 Dec 28;14(1):31167. doi: 10.1038/s41598-024-82470-z.
5
Analysis of the Relationship Between Parkinson's Disease and Diabetic Retinopathy Based on Bioinformatics Methods.基于生物信息学方法分析帕金森病与糖尿病视网膜病变的关系。
Mol Neurobiol. 2024 Sep;61(9):6395-6406. doi: 10.1007/s12035-024-03982-3. Epub 2024 Feb 3.
6
Possible linking and treatment between Parkinson's disease and inflammatory bowel disease: a study of Mendelian randomization based on gut-brain axis.帕金森病与炎症性肠病之间可能的联系及治疗:基于肠-脑轴的孟德尔随机化研究
J Transl Med. 2025 Jan 11;23(1):45. doi: 10.1186/s12967-024-06045-2.
7
Druggable targets for Parkinson's disease: transcriptomics based Mendelian randomization study.帕金森病的可用药靶标:基于转录组学的孟德尔随机化研究。
Sci Rep. 2024 Oct 28;14(1):25763. doi: 10.1038/s41598-024-77401-x.
8
Identification and Validation of Oxidative Stress-Related Hub Genes in Parkinson's Disease.帕金森病中氧化应激相关枢纽基因的鉴定与验证
Mol Neurobiol. 2025 May;62(5):5466-5483. doi: 10.1007/s12035-024-04622-6. Epub 2024 Nov 18.
9
Amyotrophic Lateral Sclerosis and Parkinson's Disease: Brain Tissue Transcriptome Analysis Reveals Interactions.肌萎缩侧索硬化症和帕金森病:脑组织转录组分析揭示相互作用
Mol Neurobiol. 2025 May;62(5):6383-6396. doi: 10.1007/s12035-024-04681-9. Epub 2025 Jan 10.
10
Proteome-Wide Association Study for Finding Druggable Targets in Progression and Onset of Parkinson's Disease.全蛋白质组关联研究以寻找帕金森病进展和发病过程中的可成药靶点。
CNS Neurosci Ther. 2025 Feb;31(2):e70294. doi: 10.1111/cns.70294.

引用本文的文献

1
Replication of the GWAS-Identified GALNT13 rs10196189 Polymorphism in Relation to Speed-Power Elite Active Athlete Status and Multidimensional Phenotypic Differences in Chinese Han Males: A Pilot Study.全基因组关联研究确定的GALNT13基因rs10196189多态性与速度力量型优秀现役运动员状态及中国汉族男性多维表型差异的相关性:一项初步研究
Genes (Basel). 2025 Aug 20;16(8):983. doi: 10.3390/genes16080983.

本文引用的文献

1
Plasma proteomics identify biomarkers and undulating changes of brain aging.血浆蛋白质组学可识别脑衰老的生物标志物及波动变化。
Nat Aging. 2025 Jan;5(1):99-112. doi: 10.1038/s43587-024-00753-6. Epub 2024 Dec 9.
2
Multiome-wide Association Studies: Novel Approaches for Understanding Diseases.全基因组关联研究:理解疾病的新方法
Genomics Proteomics Bioinformatics. 2024 Dec 3;22(5). doi: 10.1093/gpbjnl/qzae077.
3
Molecular Alterations in Core Subunits of Mitochondrial Complex I and Their Relation to Parkinson's Disease.线粒体复合体I核心亚基的分子改变及其与帕金森病的关系
Mol Neurobiol. 2025 Jun;62(6):6968-6982. doi: 10.1007/s12035-024-04526-5. Epub 2024 Sep 27.
4
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects.帕金森病中的维 A 酸:分子见解、治疗进展和未来前景。
Life Sci. 2024 Oct 15;355:123010. doi: 10.1016/j.lfs.2024.123010. Epub 2024 Aug 23.
5
DNA damage repair in megakaryopoiesis: molecular and clinical aspects.巨核细胞生成中的 DNA 损伤修复:分子与临床方面。
Expert Rev Hematol. 2024 Oct;17(10):705-712. doi: 10.1080/17474086.2024.2391102. Epub 2024 Aug 13.
6
Single-cell peripheral immunoprofiling of lewy body and Parkinson's disease in a multi-site cohort.多中心队列中单细胞外周免疫谱分析路易体和帕金森病。
Mol Neurodegener. 2024 Aug 1;19(1):59. doi: 10.1186/s13024-024-00748-2.
7
An update on novel and emerging therapeutic targets in Parkinson's disease.帕金森病中新的和新兴治疗靶点的研究进展。
Metab Brain Dis. 2024 Aug;39(6):1213-1225. doi: 10.1007/s11011-024-01390-z. Epub 2024 Jul 27.
8
Multiomics of parkinsonism cynomolgus monkeys highlights significance of metabolites in interaction between host and microbiota.帕金森病食蟹猴的多组学研究突出了代谢物在宿主与微生物群相互作用中的重要性。
NPJ Biofilms Microbiomes. 2024 Jul 26;10(1):61. doi: 10.1038/s41522-024-00535-3.
9
Risk of Dementia in Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病患者痴呆风险:系统评价和荟萃分析。
Mov Disord. 2024 Oct;39(10):1697-1709. doi: 10.1002/mds.29918. Epub 2024 Jul 22.
10
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onset.血浆蛋白质组学鉴定出可预测帕金森病的生物标志物,其可在症状出现前 7 年预测疾病。
Nat Commun. 2024 Jun 18;15(1):4759. doi: 10.1038/s41467-024-48961-3.